Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
SPDR S&P Health Care Equipment ETF (XHE) belongs to the US Health Care segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. XHE is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.75% for ARKG. XHE is down -7.18% year-to-date (YTD) with -$4M in YTD flows. ARKG performs better with -1.38% YTD performance, and -$16M in YTD flows. Run a side-by-side ETF comparison of XHE and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XHE ARKG | -5.57%-1.00% | -8.58%-6.62% | -7.18%-1.38% | -2.13%+31.18% | -6.66%+0.39% | -30.59%-67.04% |
| Flows | XHE ARKG | --$82M | -$4M-$67M | -$4M-$16M | -$44M-$207M | -$295M-$614M | -$430M-$2.74B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XHE ARKG | +18.92%+38.80% | +23.53%+44.65% | +21.08%+42.34% | +24.18%+45.24% |
| Max drawdown | XHE ARKG | -12.38%-19.50% | -14.34%-23.94% | -32.63%-51.98% | -49.90%-80.33% |
| Max drawdown duration | XHE ARKG | 61d46d | 241d77d | 1052d964d | 1650d1820d |
XHE | ARKG | |
Last sale 3/11/2026 at 1:30 PM | $82.04 | $27.67 |
| Previous close 03/10/2026 | $81.73 | $27.93 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XHE | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XHE | ARKG | |
|---|---|---|
| Last price | $82.04 | $27.67 |
| 1D performance | +0.38% | -0.93% |
| AuM | $139.06 M | $1.14 B |
| E/R | 0.35% | 0.75% |
XHE | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | SPDR | Ark Investment |
| Benchmark | S&P Health Care Equipment Select Industry Index | - |
| N° of holdings | 61 | 30 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 26, 2011 | April 2, 2019 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
